LGP announces $4 million placement and $2 million SPP
Filed with ASX · · 4 pages · English
• Company now wholly focused on achieving break-even and ultimately delivering profitable sales, including by delivering into new and existing European supply agreements and driving increased sales in Australia investors as well as commitments for a further $200,000 from the Company’s Board and Executive. Head Office PO Box 690, West Perth WA 6872 T + 61 8 6280 0050 E info@littlegreenpharma.com W
Little Green Pharma Ltd. on 6ix
Story so far
Earlier from Little Green Pharma
- Exclusive supply agreement with Cannamedical in Germany
- TGA advertising infringement notices
- Quarterly Activities Report & Appendix 4C
- Application for quotation of securities - LGP
- LGP signs $2M supply agreement with Ilios Sante
Later from Little Green Pharma
- Update Four 20 Pharma and French trial extension
- Share Purchase Plan open to eligible shareholders
- Prospectus
- LGP significantly expands flower portfolio
- Ethics approval for CBD Phase III clinical trial
Follow Little Green Pharma into a list and get an email when it puts out news.
Follow Little Green Pharma